Veterinary Medicines

Calci-kel, 279,24 mg/ml + 40 mg/ml, süstelahus veistele ja lammastele

Authorised
  • Magnesium chloride
  • Calcium gluconate
Download as PDF

Product identification

Medicine name:
Calci-kel, 279,24 mg/ml + 40 mg/ml, süstelahus veistele ja lammastele
Active substance:
  • Magnesium chloride
  • Calcium gluconate
Target species:
  • Cattle
  • Sheep
Route of administration:
  • Intravenous use

Product details

Active substance and strength:
  • Magnesium chloride
    40.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Calcium gluconate
    279.24
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intravenous use
    • Cattle
      • Meat and offal
        0
        day
      • Milk
        0
        day
    • Sheep
      • Meat and offal
        0
        day
      • Milk
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA12AX
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Estonia
Available in:
  • Estonia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Kela Kempisch Laboratorium Kela Laboratoria
Marketing authorisation date:
Manufacturing sites for batch release:
  • KELA Kempisch Laboratorium Kela Laboratoria
Responsible authority:
  • State Agency Of Medicines
Authorisation number:
  • 1192
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Estonian (PDF)
Published on: 17/07/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."